-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
Event / Presentation
2025.11.28
CHITOSE to Present on Mammalian Cell Technologies at JAACT 2025 in Osaka
-
Name Update Announcement: “MATSURI Project” Becomes “MATSURI Initiative”
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Chitose Laboratory Changes Head Office Location, Names the New Primary Operations Office “C3-Hub”
-
Event / Presentation
2025.06.03
CHITOSE Presents on Novel HAT Cell Line for AAV Manufacturing at ASGCT Annual Meeting
-
CHITOSE Group Announces Capital Increase of JPY 7.3 Billion Scale through Third-Party Allotment
-
Event / Presentation
2025.01.27
CEO Tomohiro Fujita Presented at the 19th Saudi-Japanese Business Council Meeting
-
CHITOSE Group, Prodezi Long An Corporation and TA Vital Join Forces to Build a Sustainable Industrial Park in Vietnam
